193 related articles for article (PubMed ID: 35513479)
21. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.
van Rijssel TI; de Jong AJ; Santa-Ana-Tellez Y; Boeckhout M; Zuidgeest MGP; van Thiel GJMW;
Drug Discov Today; 2022 Oct; 27(10):103326. PubMed ID: 35870693
[TBL] [Abstract][Full Text] [Related]
22. Quantifying Site Burden to Optimize Protocol Performance.
Florez M; Smith Z; Olah Z; Martin M; Getz K
Ther Innov Regul Sci; 2024 Mar; 58(2):347-356. PubMed ID: 38191957
[TBL] [Abstract][Full Text] [Related]
23. Design and Execution of Sustainable Decentralized Clinical Trials.
Singh P; Burden AM; Natanegara F; Beckman RA
Clin Pharmacol Ther; 2023 Oct; 114(4):802-809. PubMed ID: 37489911
[TBL] [Abstract][Full Text] [Related]
24. Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databases.
Sato T; Mizumoto S; Ota M; Shikano M
BMJ Open; 2023 Oct; 13(10):e074334. PubMed ID: 37821130
[TBL] [Abstract][Full Text] [Related]
25. Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials.
Boden-Albala B; Carman H; Southwick L; Parikh NS; Roberts E; Waddy S; Edwards D
Stroke; 2015 Aug; 46(8):2232-7. PubMed ID: 26185186
[TBL] [Abstract][Full Text] [Related]
26. Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent.
Raven-Gregg T; Shepherd V
Trials; 2021 Sep; 22(1):589. PubMed ID: 34479612
[TBL] [Abstract][Full Text] [Related]
27. Development of an online resource for recruitment research in clinical trials to organise and map current literature.
Kearney A; Harman NL; Rosala-Hallas A; Beecher C; Blazeby JM; Bower P; Clarke M; Cragg W; Duane S; Gardner H; Healy P; Maguire L; Mills N; Rooshenas L; Rowlands C; Treweek S; Vellinga A; Williamson PR; Gamble C
Clin Trials; 2018 Dec; 15(6):533-542. PubMed ID: 30165760
[TBL] [Abstract][Full Text] [Related]
28. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
29. Recruiting minorities into clinical trials: toward a participant-friendly system.
Swanson GM; Ward AJ
J Natl Cancer Inst; 1995 Dec; 87(23):1747-59. PubMed ID: 7473831
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
31. Examining the Association Between DCT Solutions Use and Participant Diversity in Clinical Trials.
Smith Z; Getz K
Ther Innov Regul Sci; 2024 May; ():. PubMed ID: 38734837
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
33. Valuing All Voices: refining a trauma-informed, intersectional and critical reflexive framework for patient engagement in health research using a qualitative descriptive approach.
Roche P; Shimmin C; Hickes S; Khan M; Sherzoi O; Wicklund E; Lavoie JG; Hardie S; Wittmeier KDM; Sibley KM
Res Involv Engagem; 2020; 6():42. PubMed ID: 32699647
[TBL] [Abstract][Full Text] [Related]
34. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
[TBL] [Abstract][Full Text] [Related]
35. Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations.
Sato T; Ishimaru H; Takata T; Sasaki H; Shikano M
Front Med (Lausanne); 2022; 9():903188. PubMed ID: 35733872
[TBL] [Abstract][Full Text] [Related]
36. Barriers and facilitators to recruitment in mental health services: care coordinators' expectations and experience of referring to a psychosis research trial.
Bucci S; Butcher I; Hartley S; Neil ST; Mulligan J; Haddock G
Psychol Psychother; 2015 Sep; 88(3):335-50. PubMed ID: 25257960
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
Stewart J; Krows ML; Schaafsma TT; Heller KB; Brown ER; Boonyaratanakornkit J; Brown CE; Leingang H; Liou C; Bershteyn A; Schwartz MD; Agrawal V; Friedman-Klabanoff D; Eustace S; Stankiewicz Karita HC; Paasche-Orlow MK; Kissinger P; Hosek SG; Chu HY; Celum C; Baeten JM; Wald A; Johnston C; Barnabas RV
JAMA Netw Open; 2022 Feb; 5(2):e2148325. PubMed ID: 35157053
[TBL] [Abstract][Full Text] [Related]
38. Development of an online clinical trial recruitment portal for the NIHR mental health BRC.
Markham S
Res Involv Engagem; 2016; 2():11. PubMed ID: 29062512
[TBL] [Abstract][Full Text] [Related]
39. Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.
Adashek JJ; Kurzrock R
NPJ Precis Oncol; 2023 Dec; 7(1):129. PubMed ID: 38066094
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
